Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

A new compound shows promise as a topical treatment for hair loss.

Advanced platelet-rich fibrin improves healing and reduces pain in oral surgery.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Taohong Siwu Decoction may help treat deep vein thrombosis by reducing inflammation.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Some blood thinners can cause hair loss, but switching medications can stop it.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Aloe Vera and injectable platelet-rich fibrin (i-PRF) together can speed up and improve hair growth when used in the right amounts.

The new collagen and tannic acid hydrogel effectively stops bleeding and aids tissue repair better than current options.